Skip to main content
Jafron Biomedical Co.,Ltd. logo

Jafron Biomedical Co.,Ltd. — Investor Relations & Filings

Ticker · 300529 ISIN · CNE100002995 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,842 across all filing types
Latest filing 2019-07-03 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300529

About Jafron Biomedical Co.,Ltd.

https://www.jafron.com

Jafron Biomedical Co.,Ltd. specializes in the research, development, and manufacturing of biomaterials and equipment for blood purification. The company is a primary provider of hemoperfusion technology, focusing on the production of adsorbent cartridges designed to remove specific toxins and inflammatory mediators from the bloodstream. Its core product portfolio includes the HA series of hemoperfusion cartridges, which are applied in clinical settings for end-stage renal disease, acute poisoning, critical care, and liver failure. Beyond consumables, the company develops blood purification machines and integrated treatment systems. These solutions target clinical applications in nephrology, intensive care, and hepatology. By leveraging advanced resin adsorption technology, the company provides specialized extracorporeal blood treatment options aimed at improving patient outcomes in complex medical conditions.

Recent filings

Filing Released Lang Actions
关于使用部分闲置自有资金及募集资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from a company about the use of idle funds and raised capital for cash management, specifically purchasing financial products like wealth management products and structured deposits. It includes specifics on amounts, investment terms, expected yields, risk management measures, and the impact on the company. It references prior shareholder meeting resolutions and related contracts but does not contain comprehensive financial statements or quarterly/yearly financial results. The document is a progress announcement on capital management activities rather than a full financial report or earnings release. It is not a regulatory certification or a brief report publication notice. Therefore, it fits best under Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes, including cash management and investment of idle funds.
2019-07-03 Chinese
关于原5%以上股东减持计划实施完毕的公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding the completion of a shareholding reduction plan by a shareholder holding more than 5% of the company's shares. It details the number of shares reduced, the price range, and compliance with relevant securities laws and regulations. The content focuses on changes in major shareholding levels and does not contain financial statements or management discussion. Therefore, it fits the category of Major Shareholding Notification (MRQ). The document length is short and it is not a report or a regulatory filing of financial results but a specific announcement about shareholding changes.
2019-07-01 Chinese
关于使用部分闲置自有资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by the company regarding the progress of using part of its idle own funds for cash management, including details of purchasing financial products, risk measures, and impact on the company. It references a prior shareholders' meeting resolution and provides detailed financial product purchase data and risk disclosures. There is no indication that this is a full financial report, earnings release, or management discussion. It is a specific update on capital management activities and cash management progress, which aligns with Capital/Financing Update filings. The document length is over 5,000 characters and contains substantive financial data related to capital usage, not just an announcement of a report or certification. Therefore, the best classification is Capital/Financing Update (CAP).
2019-07-01 Chinese
关于部分董事减持计划实施完毕的公告
Director's Dealing Classification · 100% confidence The document is an announcement regarding the completion of a shareholding reduction plan by a company director (李峰). It details the number of shares reduced, the method of reduction, dates, and compliance with relevant securities laws and regulations. There is no financial report, earnings data, or management discussion. The content focuses on a director's personal share transactions and compliance disclosures. Therefore, it fits the category of Director's Dealing (DIRS). The document length is short and specific to insider share transactions, confirming this classification.
2019-06-28 Chinese
关于部分理财产品到期赎回的进展公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a company regarding the progress of redemption of certain financial products (理财产品) that have matured. It details specific transactions involving the use of idle funds and raised funds for cash management, including amounts, dates, and yields. It references prior announcements and shareholder meeting resolutions related to the use of idle funds for cash management. The document is not a full financial report, earnings release, or management discussion. It is a regulatory announcement about the company's cash management activities and investment risk measures. The document length is about 5500 characters, which is relatively short and focused on a specific update rather than a comprehensive report. It fits best into the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2019-06-28 Chinese
2019年第二次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the 2019 second extraordinary general meeting (临时股东大会) of the company. It reviews the legality and validity of the meeting's convening, attendance, voting procedures, and results. The document includes detailed descriptions of the meeting notice, attendance, voting methods, and resolutions passed. It does not contain financial statements or financial performance data. It is not a report of financial results, audit, or management discussion, but a legal opinion on the shareholder meeting process and outcomes. This type of document is typically classified as a Declaration of Voting Results & Voting Rights Announcements (DVA) because it relates to the official results and legal validation of shareholder votes at a general meeting.
2019-06-26 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.